250 Mg Gefitinib Tablets IP

Name: 250 Mg Gefitinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 500 INR
Availability: InStock

Price 500 INR/ Strip

Get a Price/Quote

MOQ : 1 Strip

250 Mg Gefitinib Tablets IP Specification

Salt Composition
Gefitinib IP 250 mg

Dosage Form
Tablet

Indication
Non-small cell lung cancer (NSCLC)

Enzyme Types
Tyrosine kinase inhibitor

Feature
Oral targeted therapy for NSCLC

Ingredients
Gefitinib, inactive excipients

Application
Anti-cancer Therapy

Physical Color/Texture
White to off-white, round film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits epidermal growth factor receptor (EGFR) tyrosine kinase activity

Storage Instructions
Store below 30C in a dry place

Shelf Life
24 months

About 250 Mg Gefitinib Tablets IP

Experience a cost-effective solution for targeted cancer therapy with 250 Mg Gefitinib Tablets IP, available as a hot deal with special rates for bulk orders. Renowned for its magnificent efficacy, this uncommon oral therapy is indicated for non-small cell lung cancer (NSCLC) in adults. Each strip contains 10 standard-sized, white to off-white round film-coated tablets, securely packed in a blister pack. IP-certified and prescription-only, the tablets integrate the breathtaking power of gefitinib, a tyrosine kinase inhibitor, inhibiting EGFR activity. Enjoy remarkable clinical support while ensuring patient safety through strict regulatory compliance and printed batch numbers on each carton.

Advantages and Applications of Gefitinib Tablets IP

250 Mg Gefitinib Tablets IP is predominantly used for the oral targeted treatment of non-small cell lung cancer (NSCLC) in adults. Its main application surface is as an anti-cancer therapy, offering a unique advantage by selectively inhibiting EGFR tyrosine kinase activity, thus impeding tumor growth. The uncommon combination of efficacy and safety makes these tablets a preferred choice for oncologists seeking a dependable oral cancer management option.

Quick Dispatch, Exchange Policy, and Packaging Details

Enjoy quick dispatch of 250 Mg Gefitinib Tablets IP with transparent packaging details. Tablets arrive securely in blister packs (strip of 10) with all regulatory information, including shelf life and batch number printed on the carton. Our prompt dispatching process supports immediate needs, and the sample policy includes options for product exchange if eligible. Distributors, exporters, suppliers, and traders across India benefit from streamlined delivery and customer-focused service.

FAQ's of 250 Mg Gefitinib Tablets IP:

Q: How should 250 Mg Gefitinib Tablets IP be administered?

A: Gefitinib Tablets IP should be taken orally as prescribed by a healthcare professional, ensuring adherence to the recommended dosage regimen for optimum efficacy in targeting non-small cell lung cancer.

Q: What are the main benefits of using Gefitinib Tablets for NSCLC?

A: The tablets deliver targeted inhibition of EGFR tyrosine kinase, translating to minimized side effects, enhanced efficacy, and a cost-effective approach for adult NSCLC patients requiring oral anti-cancer therapy.

Q: When can samples of Gefitinib Tablets IP be exchanged?

A: Samples of Gefitinib Tablets IP can be exchanged in accordance with the established sample policy, provided eligibility criteria for return and exchange are met, ensuring customer satisfaction.

Q: Where is the batch number for Gefitinib Tablets IP located?

A: The batch number is clearly printed on the carton for traceability, guaranteeing regulatory compliance and facilitating the verification process of product authenticity.